dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· February 5, 2026

Central Garden & Pet reaffirms $2.70+ EPS target for 2026 while shifting focus to innovation and growth

View original at seekingalpha.com
Central Garden & Pet reaffirms $2.70+ EPS target for 2026 while shifting focus to innovation and growth Earnings Call Insights: Central Garden & Pet Company (CENT) Q1 2026 MANAGEMENT VIEW * CEO Nicholas Lahanas opened the call highlighting "improved gross margins and solid earnings per share, especially when compared t…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Central Garden & Pet expects fiscal 2026 non-GAAP diluted EPS of $2.70 or better

    80% confidence
  • It's time to pivot and focus on a growth mindset, including picking up private label, M&A, driving market share in categories, and investing in digital

    80% confidence
  • The total distribution points of products that Central Garden manufactures is up 14% year-over-year, showing optimism for growth and continued retailer support

    80% confidence
  • Shipment timing was more than half of the overall net sales decline, with portfolio optimization accounting for almost the rest

    80% confidence
  • Improved gross margins and solid earnings per share, especially when compared to a strong prior year first quarter that benefited from favorable shipment timing, promotional activity and weather

    80% confidence
  • The discipline around managing costs and operational simplicity is now firmly embedded in the company's culture

    80% confidence
  • Pet adoption has definitely hit the bottom and is tilted towards coming back up, with stabilization and positive growth in live animal business

    80% confidence
  • The company is applying the same clarity, focus and consistency to fostering a growth mindset and embedding innovation more deeply across the organization

    80% confidence
  • Net sales were $617 million, a 6% year-over-year decline with 2 primary factors that accounted for substantially all of the change: timing of retailer spring inventory shipments and continued portfolio optimization efforts

    80% confidence
  • Over the past several years, the company focused on simplifying the business, improving efficiency and maintaining profitability across both segments, and that work continues to show up in results

    80% confidence
  • Durables were about 16% of Pet segment sales in Q1, consistent with Q4, with decline north of 20%

    80% confidence
  • Inventories and barns are in great shape and the company is ready to be pressure tested if spring weather is favorable

    80% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Central Garden & Pet reaffirms $2.70+ EPS target for 2026 while shifting focus to innovation and growth: Source | Via News | fr.via.news